Pharmacovigilance is an integral part of our responsibility towards patients, healthcare professionals and pharmaceutical partners.
Pharmacovigilance is directly overseen by Dr Coulibaly Dinignako, Founder and Managing Director, working closely with Mr Assemien Jaurès, Regulatory Affairs Manager. Dr Coulibaly’s experience as a Medical Science Liaison in Europe supports this drug-safety culture.
Teams are made aware of their responsibility to recognize and report safety information.
Adverse events and other relevant safety information are collected through the appropriate pathway.
Information is transmitted according to agreed responsibilities, procedures and timelines.
Safety information is handled with appropriate confidentiality and traceability.
Dedicated contact: pv@afric-aurore.com